BMY vs MRK: Which Is the Better Dividend Stock?
A head-to-head dividend comparison of Bristol-Myers Squibb Company and Merck & Co., Inc. — yield, payout safety, growth and total return. MRK wins more categories overall.
| Metric | BMY | MRK |
|---|---|---|
| Forward yield | 4.45% | 2.83% |
| Annual dividend | $2.52 | $3.40 |
| Payout ratio | 70% | 94% |
| Years of growth | 53 yr | 55 yr |
| 5-yr dividend growth | 6.6% | 6.8% |
| 5-yr total return | -14% | 56% |
| Dividend safety score | 88 (A) | 90 (A) |
| Frequency | quarterly | quarterly |
| Market cap | $115.6B | $297.0B |
| P/E ratio | 15.9 | 33.9 |
Higher yield
BMY
4.45%
Safer dividend
MRK
Grade A
Faster growth
MRK
6.8%
BMY vs MRK — FAQ
Data refreshes daily · for informational purposes only, not investment advice.